Home

Muscular coșmar Oswald using molecular markers for inflamatory bowel disease mice tine minte împiedica miel

Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing  Pathological Inflammation in Inflammatory Bowel Diseases
Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases

Molecular classification of Crohn's disease reveals two clinically relevant  subtypes | Gut
Molecular classification of Crohn's disease reveals two clinically relevant subtypes | Gut

Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in  Murine Colitis | Journal of Nuclear Medicine
Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis | Journal of Nuclear Medicine

An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease -  Gastroenterology
An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease - Gastroenterology

A single early-in-life antibiotic course increases susceptibility to  DSS-induced colitis | Genome Medicine | Full Text
A single early-in-life antibiotic course increases susceptibility to DSS-induced colitis | Genome Medicine | Full Text

Frontiers | The Molecular Mechanisms of Intestinal Inflammation and  Fibrosis in Crohn's Disease
Frontiers | The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn's Disease

IJMS | Free Full-Text | Dysbiosis in Inflammatory Bowel Disease: Pathogenic  Role and Potential Therapeutic Targets | HTML
IJMS | Free Full-Text | Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets | HTML

Comparative severity analysis of colitis in C57BL/6 than BALB/c mice: A  novel and rapid model of DSS induced colitis | bioRxiv
Comparative severity analysis of colitis in C57BL/6 than BALB/c mice: A novel and rapid model of DSS induced colitis | bioRxiv

Reduction of inflammation and colon injury by a Pennyroyal phenolic extract  in experimental inflammatory bowel disease in mice - ScienceDirect
Reduction of inflammation and colon injury by a Pennyroyal phenolic extract in experimental inflammatory bowel disease in mice - ScienceDirect

Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis  - Gastroenterology
Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis - Gastroenterology

Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal  inflammation | Gut
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation | Gut

DSS-induced colitis is associated with adipose tissue dysfunction and  disrupted hepatic lipid metabolism leading to hepatosteatosis and  dyslipidemia in mice | Scientific Reports
DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice | Scientific Reports

Koch's postulates, microbial dysbiosis and inflammatory bowel disease -  Clinical Microbiology and Infection
Koch's postulates, microbial dysbiosis and inflammatory bowel disease - Clinical Microbiology and Infection

Frontiers | Oral Delivery of Biologics in Inflammatory Bowel Disease  Treatment
Frontiers | Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment

Rhubarb Peony Decoction ameliorates ulcerative colitis in mice by  regulating gut microbiota to restoring Th17/Treg balance - ScienceDirect
Rhubarb Peony Decoction ameliorates ulcerative colitis in mice by regulating gut microbiota to restoring Th17/Treg balance - ScienceDirect

Evaluation of anti-TNF therapeutic response in patients with inflammatory  bowel disease: Current and novel biomarkers - eBioMedicine
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine

Pathway paradigms revealed from the genetics of inflammatory bowel disease  | Nature
Pathway paradigms revealed from the genetics of inflammatory bowel disease | Nature

Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB  Activation - Cellular and Molecular Gastroenterology and Hepatology
Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation - Cellular and Molecular Gastroenterology and Hepatology

Cells | Free Full-Text | Molecular Profiling of Inflammatory Bowel Disease:  Is It Ready for Use in Clinical Decision-Making? | HTML
Cells | Free Full-Text | Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making? | HTML

Molecular classification of Crohn's disease reveals two clinically relevant  subtypes | Gut
Molecular classification of Crohn's disease reveals two clinically relevant subtypes | Gut

NCoR1 Protects Mice From Dextran Sodium Sulfate–Induced Colitis by Guarding  Colonic Crypt Cells From Luminal Insult - ScienceDirect
NCoR1 Protects Mice From Dextran Sodium Sulfate–Induced Colitis by Guarding Colonic Crypt Cells From Luminal Insult - ScienceDirect

Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That MUC2 Is  Critical for Colonic Protection - Gastroenterology
Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That MUC2 Is Critical for Colonic Protection - Gastroenterology

Uncovering the cause of ulcerative colitis - Roberts‐Thomson - 2019 - JGH  Open - Wiley Online Library
Uncovering the cause of ulcerative colitis - Roberts‐Thomson - 2019 - JGH Open - Wiley Online Library

Peptidoglycan Recognition Proteins Protect Mice from Experimental Colitis by  Promoting Normal Gut Flora and Preventing Induction of Interferon-γ -  ScienceDirect
Peptidoglycan Recognition Proteins Protect Mice from Experimental Colitis by Promoting Normal Gut Flora and Preventing Induction of Interferon-γ - ScienceDirect

IJMS | Free Full-Text | Inflammatory Bowel Disease: New Insights into the  Interplay between Environmental Factors and PPARγ | HTML
IJMS | Free Full-Text | Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ | HTML

The role of the mitochondrial protein VDAC1 in inflammatory bowel disease:  a potential therapeutic target: Molecular Therapy
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target: Molecular Therapy